Synthesis, anticancer and apoptosis-inducing activities of quinazoline–isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies

References

• Senwar KR, Reddy TS, Thummuri D, et al. Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3′-methoxy-4′-(2-amino-2-oxoethoxy)-benzylidene) indolin-2-ones as potential antitumour agents. Eur J Med Chem 2016;118:34–46.
   PubMed Web of Science ®Google Scholar
• Alaa A-M, Abou-Zeid LA, ElTahir KEH, et al. Design, synthesis of 2, 3-disubstitued 4 (3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies. Bioorg Med Chem 2016;24:3818–28.
   PubMed Web of Science ®Google Scholar
• Alaa A-M, El-Azab AS, Abou-Zeid LA, et al. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5, 5-diphenylimidazolidine-2, 4-dione scaffold: molecular docking studies. Eur J Med Chem 2016;115:121–31.
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, El-Azab AS, Mohamed MA, et al. Synthesis of some new substituted iodoquinazoline derivatives and their antimicrobial screening. J Saudi Chem Soc 2011;15:319–25.
   Web of Science ®Google Scholar
• Alanazi AM, Alaa A-M, Al-Suwaidan IA, et al. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. Eur J Med Chem 2014;79:446–54.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Al-Suwaidan IA, Alaa A-M, et al. Design, synthesis and biological evaluation of some novel substituted 2-mercapto-3-phenethylquinazolines as antitumor agents. Med Chem Res 2013;22:5566–77.
   Web of Science ®Google Scholar
• Al-Obaid A, Abdel-Hamide S, El-Kashef H, et al. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4 (3H)-quinazolinone analogs. Eur J Med Chem 2009;44:2379–91.
   PubMed Web of Science ®Google Scholar
• Al-Omar M, El-Azab A, El-Obeid S, Hamide HA. Sythesis of some new 4-(3H)-quinazoline analogs as potential antioxidant agents. Saudi J Chem Soc 2006;10:113–28.
   Google Scholar
• Al-Omary FA, Abou-Zeid LA, Nagi MN, et al. Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2, 6-substituted-quinazolin-4-ones. Bioorg Med Chem 2010;18:2849–63.
   PubMed Web of Science ®Google Scholar
• Al-Suwaidan IA, Abdel-Aziz AA-M, Shawer TZ, et al. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4 (3H) quinazolinone analogues. J Enzyme Inhib Med Chem 2016;31:78–89.
   PubMed Web of Science ®Google Scholar
• Al-Suwaidan IA, Alanazi AM, Alaa A-M, et al. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study. Bioorg Med Chem Lett 2013;23:3935–41.
   PubMed Web of Science ®Google Scholar
• AzizaNassar M, AbdelHamide M, ElHakim S, El-Azab AA. Synthesis and antimicrobial activities of some new 3-heteroaryl-quinazolin-4-ones. Indian J Heterocycl Chem 1996;6:25–30.
   Web of Science ®Google Scholar
• El-Azab AS. Synthesis of some new substituted 2-mercaptoquinazoline analogs as potential antimicrobial agents. Phosphorus Sulfur Silicon Relat Elem 2007;182:333–48.
   Web of Science ®Google Scholar
• El-Azab AS, Abdel-Hamide SG, Sayed-Ahmed MM, et al. Novel 4 (3H)-quinazolinone analogs: synthesis and anticonvulsant activity. Med Chem Res 2013;22:2815–27.
   Web of Science ®Google Scholar
• El-Azab AS, Al-Omar MA, Alaa A-M, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem 2010;45:4188–98.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, ElTahir KE. Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4 (3H)-quinazoline derivatives. Bioorg Med Chem Lett 2012;22:327–33.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, ElTahir KE. Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities. Bioorg Med Chem Lett 2012;22:1879–85.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, ElTahir KE, Attia SM. Synthesis and anticonvulsant evaluation of some novel 4 (3H)-quinazolinones. Chem Monthly 2011;142:837–48.
   Web of Science ®Google Scholar
• Mohamed MA, Ayyad RR, Shawer TZ, et al. Synthesis and antitumor evaluation of trimethoxyanilides based on 4 (3H)-quinazolinone scaffolds. Eur J Med Chem 2016;112:106–13.
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, Kadi AA, El‐Azab AS, et al. Synthesis, analgesic and anti‐inflammatory evaluation of some new 3H‐quinazolin‐4‐one derivatives. Archiv Der Pharmazie 2008;341:377–85.
   PubMed Web of Science ®Google Scholar
• Alaa A-M, Abou-Zeid LA, ElTahir KEH, et al. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4 (3H)-quinazolinones. Eur J Med Chem 2016;121:410–21.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Abdel-Aziz AA, Shawer TZ, et al. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies. J Enzyme Inhib Med Chem 2016;31:721–35.
   PubMed Web of Science ®Google Scholar
• Barlési F, Tchouhadjian C, Doddoli C, et al. Gefitinib (ZD1839, Iressa®) in non‐small‐cell lung cancer: a review of clinical trials from a daily practice perspective. Fundam Clin Pharmacol 2005;19:385–93.
   PubMed Web of Science ®Google Scholar
• Barker AJ, Gibson K, Grundy HW, et al. Studies leading to the identification of ZD1839 (Iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001;11:1911–14.
   PubMed Web of Science ®Google Scholar
• Ganjoo KN, Wakelee H. Review of erlotinib in the treatment of advanced non-small cell lung cancer. Biologics 2007;1:335–46.
   PubMedGoogle Scholar
• Ibrahim HS, Abou-Seri SM, Tanc M, et al. Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII. Eur J Med Chem 2015;103:583–93.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Michaelson MD, Redman BG, et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 2006;24:16–24.
   PubMed Web of Science ®Google Scholar
• Prenen H, Cools J, Mentens N, et al. Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate. Clin Cancer Res 2006;12:2622–7.
   PubMed Web of Science ®Google Scholar
• Teng Y-O, Zhao H-Y, Wang J, et al. Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives. Eur J Med Chem 2016;112:145–56.
   PubMed Web of Science ®Google Scholar
• Koenig M, Cui J, Wei C, et al. Indolinone hydrazides as c-Met inhibitors. Google Patents, 2006.
   Google Scholar
• Al-Suwaidan IA, Alanazi AM, El-Azab AS, et al. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2. Bioorg Med Chem Lett 2013;23:2601–5.
   PubMed Web of Science ®Google Scholar
• Radwan AA, Al-Mohanna F, Alanazi FK, et al. Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N′-(2-oxoindolin-3-ylidene)-2-(benzyloxy) benzohydrazides. Bioorg Med Chem Lett 2016;26:1664–70.
   PubMed Web of Science ®Google Scholar
• Naglah AM, Shinwari Z, Bhat MA, et al. Targeting leukemic side population cells by isatin derivatives of nicotinic acid amide. J Biol Regul Homeost Agents 2016;30:353.
   PubMed Web of Science ®Google Scholar
• Chemical Computing Group. MOE: molecular operating environment. 2008.10 of Chemical Computing Group. Inc. Available from: http://www.chemcomp.com/press_releases/2008-11-04.htm
   Google Scholar
• Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 2002;277:46265–72.
   PubMed Web of Science ®Google Scholar